Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma

A. Broniscer, R. G. Tatevossian, N. D. Sabin, Paul Klimo, J. Dalton, R. Lee, A. Gajjar, D. W. Ellison

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Aims: A few case series in adults have described the characteristics of epithelioid glioblastoma (e-GB), one of the rarest variants of this cancer. We evaluated clinical, radiological, histological and molecular characteristics in the largest series to date of paediatric e-GB. Methods: Review of clinical characteristics and therapy, imaging studies and histology was performed in patients younger than 22 years with e-GB seen at our institution over 15 years. Sequencing of hotspot mutations and fluorescence in situ hybridization of relevant genes were undertaken. Results: Median age at diagnosis of six patients was 7.6 years. Tumours originated in the cerebral cortex (n=2) or diencephalon (n=4). Three patients presented with acute, massive haemorrhage and three had leptomeningeal dissemination at diagnosis. Paediatric e-GB had the typical histological characteristics seen in adult tumours. Universal immunoreactivity for INI1 and lack of diverse protein expression were seen in all cases. One tumour had a chromosome 22q loss. Three tumours (50%) harboured a BRAF: p.V600E. One thalamic tumour had an H3F3A p.K27M. All patients received radiation therapy with (n=3) or without chemotherapy (n=3). All patients experienced tumour progression with a median survival of 169 days. One patient with nonmetastatic disease had early leptomeningeal progression. Two patients had symptomatic tumour spread outside the central nervous system (CNS) through a ventriculoperitoneal shunt. One additional patient had widespread metastases outside the CNS identified at autopsy. Conclusions: Paediatric e-GBs are rare cancers with an aggressive behaviour that share histological and genetic characteristics with their adult counterparts. BRAF inhibition is a potential treatment for these tumours.

Original languageEnglish (US)
Pages (from-to)327-336
Number of pages10
JournalNeuropathology and Applied Neurobiology
Volume40
Issue number3
DOIs
StatePublished - Jan 1 2014

Fingerprint

Glioblastoma
Pediatrics
Neoplasms
Central Nervous System
Ventriculoperitoneal Shunt
Diencephalon
Fluorescence In Situ Hybridization
Cerebral Cortex
Autopsy
Histology
Radiotherapy
Chromosomes
Hemorrhage
Neoplasm Metastasis
Drug Therapy
Mutation
Survival
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Histology
  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma. / Broniscer, A.; Tatevossian, R. G.; Sabin, N. D.; Klimo, Paul; Dalton, J.; Lee, R.; Gajjar, A.; Ellison, D. W.

In: Neuropathology and Applied Neurobiology, Vol. 40, No. 3, 01.01.2014, p. 327-336.

Research output: Contribution to journalArticle

Broniscer, A, Tatevossian, RG, Sabin, ND, Klimo, P, Dalton, J, Lee, R, Gajjar, A & Ellison, DW 2014, 'Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma', Neuropathology and Applied Neurobiology, vol. 40, no. 3, pp. 327-336. https://doi.org/10.1111/nan.12093
Broniscer, A. ; Tatevossian, R. G. ; Sabin, N. D. ; Klimo, Paul ; Dalton, J. ; Lee, R. ; Gajjar, A. ; Ellison, D. W. / Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma. In: Neuropathology and Applied Neurobiology. 2014 ; Vol. 40, No. 3. pp. 327-336.
@article{1cde5f3a6de94a83b39f941407a43d1b,
title = "Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma",
abstract = "Aims: A few case series in adults have described the characteristics of epithelioid glioblastoma (e-GB), one of the rarest variants of this cancer. We evaluated clinical, radiological, histological and molecular characteristics in the largest series to date of paediatric e-GB. Methods: Review of clinical characteristics and therapy, imaging studies and histology was performed in patients younger than 22 years with e-GB seen at our institution over 15 years. Sequencing of hotspot mutations and fluorescence in situ hybridization of relevant genes were undertaken. Results: Median age at diagnosis of six patients was 7.6 years. Tumours originated in the cerebral cortex (n=2) or diencephalon (n=4). Three patients presented with acute, massive haemorrhage and three had leptomeningeal dissemination at diagnosis. Paediatric e-GB had the typical histological characteristics seen in adult tumours. Universal immunoreactivity for INI1 and lack of diverse protein expression were seen in all cases. One tumour had a chromosome 22q loss. Three tumours (50{\%}) harboured a BRAF: p.V600E. One thalamic tumour had an H3F3A p.K27M. All patients received radiation therapy with (n=3) or without chemotherapy (n=3). All patients experienced tumour progression with a median survival of 169 days. One patient with nonmetastatic disease had early leptomeningeal progression. Two patients had symptomatic tumour spread outside the central nervous system (CNS) through a ventriculoperitoneal shunt. One additional patient had widespread metastases outside the CNS identified at autopsy. Conclusions: Paediatric e-GBs are rare cancers with an aggressive behaviour that share histological and genetic characteristics with their adult counterparts. BRAF inhibition is a potential treatment for these tumours.",
author = "A. Broniscer and Tatevossian, {R. G.} and Sabin, {N. D.} and Paul Klimo and J. Dalton and R. Lee and A. Gajjar and Ellison, {D. W.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/nan.12093",
language = "English (US)",
volume = "40",
pages = "327--336",
journal = "Neuropathology and Applied Neurobiology",
issn = "0305-1846",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma

AU - Broniscer, A.

AU - Tatevossian, R. G.

AU - Sabin, N. D.

AU - Klimo, Paul

AU - Dalton, J.

AU - Lee, R.

AU - Gajjar, A.

AU - Ellison, D. W.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Aims: A few case series in adults have described the characteristics of epithelioid glioblastoma (e-GB), one of the rarest variants of this cancer. We evaluated clinical, radiological, histological and molecular characteristics in the largest series to date of paediatric e-GB. Methods: Review of clinical characteristics and therapy, imaging studies and histology was performed in patients younger than 22 years with e-GB seen at our institution over 15 years. Sequencing of hotspot mutations and fluorescence in situ hybridization of relevant genes were undertaken. Results: Median age at diagnosis of six patients was 7.6 years. Tumours originated in the cerebral cortex (n=2) or diencephalon (n=4). Three patients presented with acute, massive haemorrhage and three had leptomeningeal dissemination at diagnosis. Paediatric e-GB had the typical histological characteristics seen in adult tumours. Universal immunoreactivity for INI1 and lack of diverse protein expression were seen in all cases. One tumour had a chromosome 22q loss. Three tumours (50%) harboured a BRAF: p.V600E. One thalamic tumour had an H3F3A p.K27M. All patients received radiation therapy with (n=3) or without chemotherapy (n=3). All patients experienced tumour progression with a median survival of 169 days. One patient with nonmetastatic disease had early leptomeningeal progression. Two patients had symptomatic tumour spread outside the central nervous system (CNS) through a ventriculoperitoneal shunt. One additional patient had widespread metastases outside the CNS identified at autopsy. Conclusions: Paediatric e-GBs are rare cancers with an aggressive behaviour that share histological and genetic characteristics with their adult counterparts. BRAF inhibition is a potential treatment for these tumours.

AB - Aims: A few case series in adults have described the characteristics of epithelioid glioblastoma (e-GB), one of the rarest variants of this cancer. We evaluated clinical, radiological, histological and molecular characteristics in the largest series to date of paediatric e-GB. Methods: Review of clinical characteristics and therapy, imaging studies and histology was performed in patients younger than 22 years with e-GB seen at our institution over 15 years. Sequencing of hotspot mutations and fluorescence in situ hybridization of relevant genes were undertaken. Results: Median age at diagnosis of six patients was 7.6 years. Tumours originated in the cerebral cortex (n=2) or diencephalon (n=4). Three patients presented with acute, massive haemorrhage and three had leptomeningeal dissemination at diagnosis. Paediatric e-GB had the typical histological characteristics seen in adult tumours. Universal immunoreactivity for INI1 and lack of diverse protein expression were seen in all cases. One tumour had a chromosome 22q loss. Three tumours (50%) harboured a BRAF: p.V600E. One thalamic tumour had an H3F3A p.K27M. All patients received radiation therapy with (n=3) or without chemotherapy (n=3). All patients experienced tumour progression with a median survival of 169 days. One patient with nonmetastatic disease had early leptomeningeal progression. Two patients had symptomatic tumour spread outside the central nervous system (CNS) through a ventriculoperitoneal shunt. One additional patient had widespread metastases outside the CNS identified at autopsy. Conclusions: Paediatric e-GBs are rare cancers with an aggressive behaviour that share histological and genetic characteristics with their adult counterparts. BRAF inhibition is a potential treatment for these tumours.

UR - http://www.scopus.com/inward/record.url?scp=84896029276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896029276&partnerID=8YFLogxK

U2 - 10.1111/nan.12093

DO - 10.1111/nan.12093

M3 - Article

C2 - 24127995

AN - SCOPUS:84896029276

VL - 40

SP - 327

EP - 336

JO - Neuropathology and Applied Neurobiology

JF - Neuropathology and Applied Neurobiology

SN - 0305-1846

IS - 3

ER -